IRadimed Corp
SWB:46K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IRadimed Corp
SWB:46K
|
US |
|
A
|
Aura Minerals Inc
OTC:ORAAF
|
US |
|
A
|
Advanced Proteome Therapeutics Corporation
OTC:APTCF
|
US |
|
Principal Solar Inc
OTC:PSWW
|
US |
|
RenovaCare Inc
OTC:RCAR
|
US |
|
A
|
AKD Hospitality Ltd
KAR:AKDHL
|
PK |
|
P
|
Perimeter Medical Imaging AI Inc
OTC:PYNKF
|
CA |
|
ICU Medical Inc
NASDAQ:ICUI
|
US |
|
I
|
Inflection Point Acquisition Corp II
NASDAQ:IPXX
|
US |
|
St Barbara Ltd
F:BM10
|
AU |
|
ENGlobal Corp
NASDAQ:ENG
|
US |
|
M
|
MTQ Corporation Ltd
SGX:M05
|
SG |
|
G
|
Georgia Capital PLC
XBER:2IX
|
UK |
|
B
|
Bangkok Union Insurance PCL
SET:BUI
|
TH |
|
Sangoma Technologies Corp
F:54GA
|
CA |
Wall St Price Targets
46K Price Targets Summary
IRadimed Corp
According to Wall Street analysts, the average 1-year price target for 46K is 103.99 EUR with a low forecast of 101.22 EUR and a high forecast of 108.86 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 46K's stock price target?
Price Target
103.99
EUR
According to Wall Street analysts, the average 1-year price target for 46K is 103.99 EUR with a low forecast of 101.22 EUR and a high forecast of 108.86 EUR.
What is the Revenue forecast for IRadimed Corp?
Projected CAGR
11%
Over the last 12 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for IRadimed Corp?
Projected CAGR
12%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for IRadimed Corp?
Projected CAGR
13%
Over the last 12 years, the compound annual growth rate for Operating Income has been 20%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for IRadimed Corp?
Projected CAGR
16%
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 21%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for IRadimed Corp?
Projected CAGR
16%
Over the last 12 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 16%.
